Variable | Study Site n mean ± SD | 2001–2003 % median (25%–75%) | STS (2001–03) % median (25%–75%) | P-Value |
---|---|---|---|---|
No. of Patients | 504 | Â | 448841 | Â |
Demographics/Risk Factors | Â | Â | Â | Â |
Age (yrs) | 64 ± 11 | 65 (56–72) | 66 (57–74) |  |
Male | 368 | 73.0 | 71.3 | .433 |
Caucasian | 474 | 94.0 | 87.1 | <.001 |
Black | 5 | 1 | 5.17 | <.001 |
Hispanic/Other | 25 | 4.96 | 6.84 | Â |
BSA (m2) | 2.08 ± 0.25 | 2.08 (1.89–2.26) | 1.95 (1.82 – 2.13) | <.001 |
Obese (BMI>35 kg/m2) | 103 | 20.4 | 13.4 | <.001 |
Current Smoker | 101 | 20 | 22.1 | .295 |
Family History of CAD | 403 | 80 | 43.2 | <.001 |
Diabetes | 168 | 33.30 | 35.0 | .469 |
Insulin-dependent | 41 | 8.13 | 10.47 | .102 |
Hypercholesterolemia | 323 | 64 | 68.49 | .038 |
Renal Failure | 10 | 1.98 | 5.20 | .002 |
Hypertension | 358 | 71 | 74.78 | .060 |
Peripheral Vascular Disease | 35 | 6.94 | 15.80 | <.001 |
Cerebrovascular Disease | 60 | 11.90 | 13.21 | .425 |
COPD | 68 | 13.50 | 18.61 | .004 |
Myocardial Infarction | 266 | 52.80 | 45.53 | <.001 |
Congestive Heart Failure | 44 | 8.73 | 13.80 | <.001 |
Unstable | 222 | 44.10 | 47.05 | .193 |
Arrhythmia (any) | 42 | 8.30 | 9.43 | .443 |
Triple Vessel Disease | 422 | 83.70 | 74.63 | <.001 |
Left Main Disease >50% | 118 | 23.40 | 24.54 | .594 |
Ejection Fraction (%) | 48 ± 11 | 50 (40–55) | 50 (40–60) |  |
Previous CV intervention | 116 | 23.00 | 20.36 | .155 |
Operative Data | Â | Â | Â | Â |
Elective | 129 | 25.60 | 51.88 | <.001 |
Emergent | 63 | 12.50 | 4.10 | <.001 |
Redo Surgery | 15 | 2.98 | 8.93 | <.001 |
No. of Grafts | 3.58 ± 1.01 |  |  |  |
Arterial | 1.63 ± 0.98 |  |  |  |
Vein | 1.94 ± 0.98 |  |  |  |
ITA Used | 473 | 93.80 | 89.84 | .004 |
Left ITA used | 471 | 93.50 | 89.34 | .004 |
Aortic Cross-Clamp (min) | 58 ± 22 | 55 (45–68) | 63 (47 – 83) | .004 |
Perfusion time (min) | 90 ± 31 | 85 (70–106) | 94 (73 – 119) |  |
Off-pump | 21 | 4.17 | 20.48 | <.001 |
STS Predicted Mortality (%) | 2.94 ± 5.0 |  | 3.13 |  |